Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (5382)

7/19/2019 11:24:32 AM

From: richardred

Respond to of 7239

HBIO- Speculation-IMO this recent activism made sense. Especially when the previous board already re-structured the company to prove the company was worth more than a 5 dollar 2007 Skystone Advisors LLC PE bid . What does the new board do, re-structure again? IMO Many divisions HBIO has can be broken up and sold if PE is bold enough to follow through? HBIO division workers would be better off in the hands of larger company with greater resources and complimentary products lines.

To: richardred who wrote (4332) 1/17/2017 12:23:54 PM
From: richardred Read Replies (1) of 5383

Added to HBIO today. Hedge funds have a sizable interest. The company has been unsuccessful in bringing about a higher stock currently, than a previous PE bid. URL below is why it's in 2017 Top Ten SITT list. IMO the company is more undervalued now than then. The company even trades at a greater discount from the stingy TO bid that was made in 2007. Reminds me of an old successful TO favorite NBSC . Eppendorf To Acquire New Brunswick Scientific For $110Mln [NBSC]. They say it's rare for lightning to strike twice in the same place. However IMO HBIO is holding a ROD.

siliconinvestor.com

P.S.

in-pharmatechnologist.com